Possible cardiovascular effects secondary to topical ophthalmic 2.5% phenylephrine.
D002318:Cardiovascular Diseases / Q000139:chemically induced*; D005128:Eye Diseases / Q000188:drug therapy; D006801:Humans; D009883:Ophthalmic Solutions; D010656:Phenylephrine / Q000008:administration & dosage / Q000009:adverse effects*
D009883:Ophthalmic Solutions; D010656:Phenylephrine